Article Information
History
- February 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Raquel Rubio-Acero1,*,
- Noemi Castelletti1,2,*,
- Volker Fingerle3,4,
- Laura Olbrich1,3,
- Abhishek Bakuli1,
- Roman Wölfel3,6,
- Philipp Girl3,6,
- Katharina Müller3,6,
- Simon Jochum7,
- Matthias Strobl7,
- Michael Hoelscher1,3,5,
- Andreas Wieser1,3,# and
- on behalf of the KoCo19 study team
- 1Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, 80802 Munich, Germany
- 2Institute of Radiation Medicine, Helmholtz Zentrum München, 85764 Neuherberg, Germany
- 3German Center for Infection Research (DZIF), partner site Munich, Germany
- 4Bavarian Health and Food Safety Authority (LGL)
- 5Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany
- 6Bundeswehr Institute of Microbiology, 80937 Munich, Germany
- 7Roche Diagnostics GmbH, 82377 Penzberg, Germany
- ↵#Correspondence
: Andreas Wieser, MD, Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Leopoldstr. 5, 80802 Munich, Germany, Tel.: +49 89 2180 78 296; E-mail: Wieser{at}mvp.lmu.de
↵* authors contributed equally/share first authorship
Posted February 23, 2021.
In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients
